Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.16 is 10% below its 5-year average of 6.85, around the middle of its 5-year range (4.01–9.75).
As of the fiscal period ended Tuesday, June 30, 2026. 28.00% above its 12-month average of 4.81.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.16.
QUICK RATIO (ACID-TEST)
6.16
QUICK RATIO (ACID-TEST) AVG TTM
4.81
QUICK RATIO (ACID-TEST) AVG 3Y
6.40
QUICK RATIO (ACID-TEST) AVG 5Y
6.85
QUICK RATIO (ACID-TEST) AVG 10Y
8.40
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.00%
CURRENT VS 3Y AVG
-3.88%
CURRENT VS 5Y AVG
-10.07%
CURRENT VS 10Y AVG
-26.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.28
median of 101 covered companies
CURRENT VS SECTOR MEDIAN
+380.97%
vs the sector median at left
Inspire Medical Systems, Inc.
Market Cap
$2.02B
Quick Ratio (Acid-Test)
6.16
TTM Avg
4.81
3Y Avg
6.40
5Y Avg
6.85
Market Cap
$1.90B
Quick Ratio (Acid-Test)
0.96
TTM Avg
0.99
3Y Avg
1.34
5Y Avg
1.34
Market Cap
$2.16B
Quick Ratio (Acid-Test)
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
Market Cap
$1.71B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$2.52B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
Market Cap
$2.76B
Quick Ratio (Acid-Test)
6.07
TTM Avg
7.05
3Y Avg
8.10
5Y Avg
8.04
Market Cap
$1.00B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$474.59M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | $2.02B | 6.16 | 4.81 | 6.40 | 6.85 |
| Fortrea Holdings Inc. (FTRE)vs › | $1.90B | 0.96 | 0.99 | 1.34 | 1.34 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | 5.03 | 4.66 | 4.92 | 7.11 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 1.07 | 0.89 | 0.95 | 0.97 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 6.65 | 5.42 | 7.28 | 7.47 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | 14.57 | 8.96 | 7.17 | 6.28 |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 6.07 | 7.05 | 8.10 | 8.04 |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.81 | 2.16 | 2.71 | 2.89 |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | 3.35 | 2.92 | 4.56 | 5.25 |
| NRC Health (NRC)vs › | $458.62M | 0.65 | 0.55 | 0.77 | 1.10 |
Quick Ratio
6.16
Excludes inventory
Current Ratio
8.55
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.16 |
| 2026-03-31 | 4.48 |
| 2025-12-31 | 4.56 |
| 2025-09-30 | 4.01 |
| 2025-06-30 | 4.84 |
| 2025-03-31 | 7.44 |
| 2024-12-31 | 6.22 |
| 2024-09-30 | 6.94 |
| 2024-06-30 | 8.35 |
| 2024-03-31 | 7.25 |
| 2023-12-31 | 7.17 |
| 2023-09-30 | 7.76 |
| 2023-06-30 | 8.09 |
| 2023-03-31 | 8.65 |
| 2022-12-31 | 8.47 |
| 2022-09-30 | 9.75 |
| 2022-06-30 | 5.15 |
| 2022-03-31 | 5.57 |
| 2021-12-31 | 6.08 |
| 2021-09-30 | 7.14 |
| 2021-06-30 | 9.70 |
| 2021-03-31 | 12.84 |
| 2020-12-31 | 12.61 |
| 2020-09-30 | 14.18 |
| 2020-06-30 | 19.72 |
| 2020-03-31 | 10.80 |
| 2019-12-31 | 9.78 |
| 2019-09-30 | 13.05 |
| 2019-06-30 | 20.05 |
| 2019-03-31 | 23.69 |
| 2018-12-31 | 17.63 |
| 2018-09-30 | 16.71 |
| 2018-06-30 | 13.86 |
| 2018-03-31 | 2.97 |
| 2017-12-31 | 2.86 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
